Wolfe Research initiated coverage of Clarivate (CLVT) with a Peer Perform rating and $4-$5 fair value range. The company has a strong market share with limited competition, but faces risks from tighter university and healthcare budgets, artificial intelligence disintermediation, and a relatively high net leverage ratio, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLVT:
- Clarivate to provide China Petrochemical with academic research, IP solutions
- Clarivate to provide library solutions, services to University of Melbourne
- Clarivate Increases Revolving Credit by $75 Million
- Milestone Scientific appoints Hines as CEO
- Clarivate’s Mixed Performance: Strong Financials Amid Strategic Uncertainty